Kjell Tore Kirketeig • 1959 • Trondheim • 10 roles • 5 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
E E.K. REVISJON AS	Managing Director/CEO	33,375,566	124,758	50 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
S SWISSCLINICAL NORWAY AS	Chairman	-	-38,123	100 % directly
K KINGSINVEST AS	Chairman	287,000	6,985,776	100 % indirectly
A ACCENSUS AS	Chairman	600,000	13,170,214	100 % directly
E E.K. REVISJON AS	Board Member	33,375,566	124,758	50 % indirectly
H HELSTØPT TRONDHEIM AS KONKURSBO Closed	Auditor	-	-	-
O ORKLA-BYGG AS KONKURSBO Closed	Auditor	-	-	-
R RIANGALLERIET SA	Board Member	-	-	-
H HARMANKAYA AS KONKURSBO Closed	Auditor	-	-	-
S SAMEIET LENSMANNSGÅRDEN	Board Member	-	-	-

Last update: Mar 2, 2026

Related industries

4

Construction
Contractor activities
Goods and trade
Purchase and sale
Transport
Delivery and mail
Services
Accounting

Direct relationships

5

PC
Pål Christian Garlie1971
ORKLA-BYGG AS KONKURSBO, HARMANKAYA AS KONKURSBO
SS
Ståle Spjøtvold1972
HELSTØPT TRONDHEIM AS KONKURSBO
IA
Ivar Andreas Sellæg Asbøll1967
RIANGALLERIET SA
AL
Asbjørn Lorents Hagerup1948
RIANGALLERIET SA
SE
Solvår Elisabeth Rustad Rian1954
RIANGALLERIET SA

Shares owned by Kjell Tore Kirketeig

Name	Share class	Total operating income	Total equity	Share
A ACCENSUS AS	Ordinære aksjer	600,000	13,170,214	100 % directly
S SWISSCLINICAL NORWAY AS	Ordinære aksjer	0	-38,123	100 % directly
K KINGSINVEST AS		287,000	6,985,776	100 % indirectly
E E.K. REVISJON AS		33,375,566	124,758	50 % indirectly
A AKER ASA	NO0010234552	0	18,422,000,000	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025